esophageal adenocarcinoma and high-grade dysplasia, according to a study published in American Journal of Gastroenterology.

Detailed price information for Bausch Health Companies Inc (BHC-T) from The Globe and Mail including charting and trades.

It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the ...

Detailed price information for Bausch Health Companies Inc (BHC-T) from The Globe and Mail including charting and trades.

the lifelong management and the overlap with the gastroenterology market. Patients with EoE usually present with heartburn symptoms and difficulty swallowing. The unmet need is significant given ...

Questor Technology Inc. ("Questor", the "Company"), announced today a $0.9 million purchase order to supply a clean combustion solution to manage a variety of railcar vapours at a Caltrax Inc.

VOQUEZNA® (vonoprazan) generated $55.3 million in 2024 net revenues in its first full year of launch, driven by strong demand, including $29.7 million in Q4, an 81% increase from Q3Over 300,000 filled ...

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP Clears the way to finalize Phase 3 protocol and recruit sites for U.S.